Google
SXTPW — 60 DEGREES PHARMACEUTICALS, INC. WARRANT (Healthcare >> Biotechnology)
SXTPW FAQ
What is SXTPW's ROE?
60 DEGREES PHARMACEUTICALS, INC. WARRANT reports a Return on Equity (ROE) of -159.81%.
What is SXTPW's dividend yield?
60 DEGREES PHARMACEUTICALS, INC. WARRANT offers a dividend yield of 0.00%.
What is SXTPW's Deepscope Quality Score?
Deepscope rates SXTPW's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy SXTPW?
Deepscope's AI Timing Score for SXTPW is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does SXTPW belong to?
60 DEGREES PHARMACEUTICALS, INC. WARRANT is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 0.04
Price
-0.00
(-1.81%)
Day Change
|
|
|---|
SXTPW, the overall quality is not good ( Quality = 31) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROA is too relatively low compare to ROE
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not good , ...
| Quality Factors |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 75 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.04 |
| PBV / Sector |
N/A / 4.63
|
| Earning Per Share | N/A |
| PE / Sector |
N/A / 17.43
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
124.048270000000
|
| Average 1W Daily Value |
112.118760000000
|
| Timing Factors |
|
42% |
| Financial Health |
|
50% |
| Ability to Make Profit |
|
43% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:08:43 |
| Symbol | SXTPW |
| Name | 60 DEGREES PHARMACEUTICALS, INC. WARRANT |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 0.00 |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | N/A / 8,857.28 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Description: 60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
